Not every practice should add regenerative medicine. The category is sold as an obvious upgrade for any clinic with musculoskeletal patients, and that is not true. The practices that do well share a specific set of conditions, and the ones that struggle are usually missing the same two.

A practice is ready when four things are true: you already see the patient population, someone can own a multi-week five-figure sales conversation, you can fund a six-month ramp, and leadership will hold a candidacy standard that turns patients away. Missing the middle two is what predicts failure.

1. Do You Already See These Patients?

The single strongest predictor. Pull your charts and count patients with chronic musculoskeletal complaints who have plateaued on conservative care and have not had surgery. Which of those complaints to build the first protocol around is a separate decision — see choosing your first indication.

If that number is substantial, you own the expensive asset — demand you do not have to buy. If it is thin, you are not adding a service line to an existing base, you are starting a patient-acquisition business, which is a much harder and more expensive project than most practices are imagining.

Ready if: a chart review produces dozens of plausible candidates today.

2. Who Will Own the Patient Conversation?

The question that decides it, and the one most practices answer vaguely. "The provider will discuss it" or "our front desk handles inquiries" both mean nobody owns it.

Somebody has to run consultations, present a five-figure price without flinching, and follow up for weeks with patients who go quiet. That is a defined role with defined time, whether it is a new hire or an existing person whose other duties are genuinely reduced.

If you cannot name the person and say what comes off their plate, the practice is not ready — and adding clinical capability will not change that. Our coordinator training guide covers what the role requires. The clinical hire is a separate decision with its own tradeoffs — MD or DNP.

Ready if: you can name the person and the hours.

3. Can You Fund Six Months?

Provider time, a coordinator, sourcing, and software are paid from month one. First cases typically close around month three, predictable revenue later.

That gap is where practices get into trouble — not on the setup cost, but on the ramp. A practice that needs the line to contribute by month two will pull funding right before the first cohort matures, then conclude it did not work.

Ready if: you can carry the line for six months without needing it to pay for itself. The model is in what it costs to add a service line.

4. Will You Turn Patients Away?

This one is cultural rather than financial, and it separates practices that last from practices that get into trouble.

Regenerative medicine does not help everyone. A practice that treats marginal candidates gets poor outcomes, damages the referral reputation that eventually becomes its cheapest acquisition channel, and in a category already under scrutiny invites the wrong kind of attention.

The test is whether leadership will hold a candidacy standard when the month is slow. That is when it gets hard, and it is the moment that determines which kind of clinic you become.

Ready if: you can state today who you would decline, and mean it.

Signals You Are Not Ready Yet

Your current conversion is weak. If the practice already struggles to convert consultations for what it sells now, adding a harder, more expensive sale makes that worse. Fix conversion on the existing business first — it lifts everything and costs nothing to add.

You want revenue this quarter. The decision cycle alone rules that out.

Nobody internally is enthusiastic. A service line with no champion drifts. Somebody has to want it.

You are adding it because competitors did. That motivation tends to produce a half-built version, which performs worse than not offering it at all.

The Honest Alternative

If two or more of the four are missing, the better move is usually to improve what you already sell.

Most practices have more recoverable revenue in their existing conversion and follow-up than in a new service line. Moving close rate on current services, working the leads already arriving, and tightening follow-up require no new capability and pay back immediately.

Regenerative medicine will still be available in a year, and you will be far better positioned to run it — because the sales function it demands is the same one that improves everything else. Our close rate guide is the place to start.

Frequently Asked Questions

We meet three of four. Should we proceed?

Depends which one is missing. Funding or patient volume can sometimes be worked around with a slower start. Missing an owner for the patient conversation is the one that reliably predicts failure — solve that before starting.

Can we test it without fully committing?

Yes. Run a chart review, identify candidates, and have real conversations about a hypothetical program before investing in capability. If your own patients are not interested, you have learned something valuable for the cost of a few afternoons.

Is a small practice too small for this?

Not inherently. Small practices with a strong relationship-based patient base often convert better than larger volume-driven ones. Size matters less than whether someone can own the conversation.

What if our provider is skeptical of regenerative medicine?

Take that seriously rather than working around it. A skeptical provider who becomes convinced by evidence makes a far more credible clinician in the consultation than an enthusiastic one. An unconvinced provider performing procedures is a problem waiting to surface.

Want an honest read on your practice? Book a free strategy call.